title: Increased formation of F(2)-isoprostanes in patients with severe heart failure.
authors.affiliation: Laboratory of Pharmacology LSCPA EA2937 Faculté de Médecine de Grenoble F-38706 La Tronche Cedex, France. Jean-Luc.Cracowski@ujf-grenoble.fr
authors.forename: J L
authors.initials: JL
authors.lastname: Cracowski
authors.forename: F
authors.initials: F
authors.lastname: Tremel
authors.forename: C
authors.initials: C
authors.lastname: Marpeau
authors.forename: J P
authors.initials: JP
authors.lastname: Baguet
authors.forename: F
authors.initials: F
authors.lastname: Stanke-Labesque
authors.forename: J M
authors.initials: JM
authors.lastname: Mallion
authors.forename: G
authors.initials: G
authors.lastname: Bessard
mesh_terms: D000328:Adult; D000368:Aged; D015415:Biomarkers / Q000652:urine; D016022:Case-Control Studies; D015232:Dinoprostone / Q000031:analogs & derivatives* / Q000652:urine; D005260:Female; D006333:Heart Failure / Q000652:urine*; D006801:Humans; D015227:Lipid Peroxidation; D008297:Male; D008875:Middle Aged; D012044:Regression Analysis
chemical_list: C108943:12-isoprostaglandin F(2alpha); D015415:Biomarkers; D015232:Dinoprostone